Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 111   

Articles published

JNJ 102.51 -0.29 (-0.28%)
price chart
Johnson & Johnson could bring 700 jobs to Tampa area
TAMPA - State and Hillsborough County officials are working on a taxpayer-funded incentive package aimed at luring the pharmaceutical and consumer goods giant Johnson & Johnson to add upwards of 700 jobs here that would pay an average annual ...
Hillsborough in hunt for up to 700 Johnson & Johnson jobs  Tampabay.com
South Carolina court orders Johnson & Johnson to pay $136 million in Risperdal ...
(Reuters) - South Carolina's Supreme Court ordered Johnson & Johnson to pay a penalty of $136 million, upholding a jury's finding that the drugmaker's Janssen unit had improperly marketed its anti-psychotic drug Risperdal and concealed its risks.
Johnson & Johnson loses first Risperdal jury trial  Philly.com
Johnson & Johnson Loses Trial Over Risperdal And Male Breasts  Wall Street Journal (blog)
Johnson & Johnson Projects Aim to Spot Who'll Get a Disease
Imagine being able to identify who is likely to develop a particular disease - and then stop the disorder before it starts. That's the goal of three research projects launched by Johnson & Johnson's pharmaceutical research arm, Janssen Research ...
Cramer: Pharmacyclics-Johnson & Johnson Deal Unlikely at This Price
It seems unlikely that Johnson & Johnson CEO Alex Gorsky would be that "undisciplined" to pay so much for the company, Cramer said on CNBC's "Stop Trading" segment.
Pharmacyclics, Inc. Said To Consider A Sale; Johnson & Johnson, Novartis ...  Bidness ETC
Pharmacyclics (PCYC) Jumps 16.9% on Takeover Rumors  Zacks.com
Johnson & Johnson Investors Should Welcome The Acquisition Of Pharmacyclics
Pharmacyclics' (NASDAQ:PCYC) stock has been on a tear the last few months, with the latest jump being a near 17% intraday gain after Bloomberg reported the company is mulling a potential sale.
Boston Scientific will pay Johnson & Johnson $600M to end lawsuit over 2006 ...
NEW YORK - Boston Scientific will pay $600 million to settle with drugmaker Johnson & Johnson over the medical device maker's $27 billion acquisition of Guidant Corp.
Johnson & Johnson's shared services search comes amid a cost-cutting move
The company is confident it can make that massive cut over three years by taking a fresh look at how it performs support functions, such as IT, finance and human resources, and bringing standardization and commonality across the business systems shared ...
Johnson & Johnson Loses Risperdal Jury Trial After Young Man Grew 46 DD ...
A Philadelphia jury said Tuesday that drugmaker Johnson & Johnson should pay $2.5 million to a 20-year-old man with autism from Alabama - who developed size 46 DD breasts as a young teenager - because the company failed to adequately warn of ...
Autistic Man Wins $2.5M In Damages After Antipsychotic Drug Gives Him 46DD ...  Medical Daily
Man Who Grew 46DD Breasts Wins $2.5M Drug Suit  Newser
Boston Scientific settles $7.2B lawsuit brought by Johnson & Johnson for $600M
Johnson & Johnson (NYSE: JNJ) claimed in the lawsuit that Guidant, for which Boston Scientific paid $27 billion, broke the terms of an earlier contract to be acquired by J&J by providing information to BSX.
Boston Scientific settles suit by Johnson & Johnson  Worcester Business Journal
Johnson & Johnson ordered to pay $2.5 million to family of man who grew breasts
After the verdict was reached, a Johnson & Johnson representative insisted that the company had issued adequate warnings about possible side effects in the medication's label and said it was considering an appeal.